We found that CELF2 expression was significantly down‐regulated in bladder urothelial carcinoma (BLCA), BRCA, colon adenocarcinoma (COAD), head and neck squamous cell carcinoma (HNSC), LUAD, LUSC, prostate adenocarcinoma (PRAD), rectum adenocarcinoma (READ), stomach adenocarcinoma (STAD), thyroid carcinoma (THCA) and uterine corpus endometrial carcinoma (UCEC) relative to their respective adjacent normal tissues. Here, CELF2 is linked to uterine corpus endometrial carcinoma.